Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level.

@article{Nascimento2011PersistentDA,
  title={Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level.},
  author={Caroline Costa do Nascimento and Isabelle Borget and Abir Al Al Ghuzlan and D{\'e}sir{\'e}e D{\'e}andr{\'e}is and Linda Chami and Jean Paul Travagli and Dana M. Hartl and J. Lumbroso and Claire Chougnet and Ludovic Lacroix and Eric Baudin and Martin Schlumberger and Sophie Leboulleux},
  journal={Endocrine-related cancer},
  year={2011},
  volume={18 2},
  pages={R29-40}
}
(131)I is given in differentiated thyroid cancer (DTC) without taking into account thyroglobulin (Tg) levels at the time of ablation, whereas 6-18 months later it is a major criterion for cure. This single-center retrospective study assessed the frequency and risk factors for persistent disease on postablation whole body scan (WBS) and postoperative neck ultrasonography (n-US) and for recurrent disease during the subsequent follow-up, in patients with DTC and undetectable TSH-stimulated Tg… CONTINUE READING

From This Paper

Figures and tables from this paper.

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 40 references

cancer patients

  • LJ DeGroot, EL Kaplan, M McCormick, FH Straus
  • 1990
Highly Influential
13 Excerpts

Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients

  • HP Tala Jury, MG Castagna, C Fioravanti, C Cipri, E Brianzoni, F Pacini
  • Journal of Clinical Endocrinology and Metabolism
  • 2010
3 Excerpts

Thyroid gland

  • M Gospodarowicz, A Bachelot, +7 authors M Schlumberger
  • 2010

Similar Papers

Loading similar papers…